LPCN
Lipocine Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.18
−2.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 40.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.82x
- Price / sales
- 11.43x
- Price / cash flow
- -1.60x
Enterprise value
- Enterprise value
- -$5.3M
- EV / sales
- -3.40x
- EV / EBITDA
- 0.45x
- EV / EBIT
- 0.42x
- Market cap
- $17.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026